...
首页> 外文期刊>Medicine. >Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis
【24h】

Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis

机译:基于SEER的美国1973年至2014年透明细胞肾细胞癌的发生率,发生率和生存结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The epidemiological and prognostic data focusing on clear cell renal cell carcinoma (ccRCC) are rarely presented. This study was aimed to define the frequency, incidence, and survival outcomes of ccRCC in the United States. The Surveillance, Epidemiology, and End Results ( SEER ) database was searched for patients with ccRCC from 1973 to 2014. Two patient cohorts were utilized: patient cohorts of SEER 18 registries and 9 registries. Overall survival was determined with Kaplan–Meier method and compared across groups with log-rank test. The incidence rate of ccRCC increased with advancing age, peaked in individuals aged 60 to 79 years, and declined in individuals aged ≥80 years. The incidence rate of ccRCC was significantly higher in males than females (1.94: 1, P .0001), in Whites than Blacks or others (1:0.79:0.91, P .0001). The incidence rate of ccRCC with right side as primary origin was slightly but significantly higher than that with left side as primary origin (1:0.96, P = .0006). The incidence rate of ccRCC in Grade II was higher than other grades. Generally, the incidence rates of ccRCC in most circumstances started to surge in the middle 1990s. Survival outcomes of ccRCC worsened with advancing age at diagnosis, tumor grade, and stage. A better prognosis was observed in females than males, in Whites than Blacks, and in individuals diagnosed in 2006 to 2014 than 1973 to 2005. To the best of our knowledge, the present study firstly presented long-term and updated epidemiological and prognostic data concerning ccRCC in the United States. Significant differences in incidence rates and survival outcomes stratified by different variables were identified.
机译:很少有针对透明细胞肾细胞癌(ccRCC)的流行病学和预后数据。这项研究旨在确定ccRCC在美国的发生频率,发生率和生存结果。搜索“监测,流行病学和最终结果(SEER)”数据库,以查找1973年至2014年患有ccRCC的患者。使用了两个患者队列:SEER 18个注册表和9个注册表的患者队列。使用Kaplan-Meier方法确定总生存期,并使用对数秩检验比较各组。 ccRCC的发生率随年龄的增长而增加,在60至79岁的人群中达到峰值,而在80岁以上的人群中则下降。男性的ccRCC发病率显着高于女性(1.94:1,P <.0001),白人高于黑人或其他人群(1:0.79:0.91,P <.0001)。以右侧为主要来源的ccRCC的发生率略高,但明显高于以左侧为主要来源的ccRCC的发生率(1:0.96,P = .0006)。 II级ccRCC的发生率高于其他级别。通常,在大多数情况下,ccRCC的发病率在1990年代中期开始激增。 ccRCC的生存结局随着诊断,肿瘤分级和阶段年龄的增加而恶化。在2006年至2014年间,女性比男性,白人比黑人,以及在2006年至2014年被确诊的个体的预后要好于1973年至2005年。就我们所知,本研究首先提供了有关以下方面的长期和最新流行病学及预后数据: ccRCC在美国。确定了不同变量分层的发病率和生存结果的显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号